Improved renal allograft survival in children treated with FK 506 (tacrolimus) rescue therapy |
| |
| Authors: | Howard E. Corey Vivian Tellis Richard Schechner Stuart M. Greenstein |
| |
| Affiliation: | (1) Department of Pediatrics, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York, USA, US;(2) Department of Surgery, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York, USA, US |
| |
| Abstract: | FK 506 has been reported to be effective in reversing acute renal allograft rejection that is resistant to steroids and to OKT3. The contribution of FK 506 “rescue” therapy to long-term graft survival has not been determined. We report 23 children transplanted between January 1993 and December 1994, 10 of whom received FK 506 “rescue” therapy. Acute rejection was reversed in 8 of 10, with 7 of the remaining grafts still functioning after a mean follow-up of 10.9±7.8 (SD) months (range 1 – 26 months). The actuarial 1-year graft survival rate was 86% compared with 66% for historical controls (P <0.05). We conclude that FK 506 may provide long-term benefits to children facing allograft loss due to acute rejection. Received August 15, 1995; received in revised form and accepted April 1, 1996 |
| |
| Keywords: | : Allograft rejection FK 506 |
| 本文献已被 SpringerLink 等数据库收录！ |
|
